Cargando…
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
Intravenous tranexamic acid (TXA) reduces death because of bleeding in patients with trauma and postpartum haemorrhage. However, in some settings intravenous injection is not feasible. To find different routes of administration, we first need to determine the minimal concentration of TXA in the bloo...
Autores principales: | Picetti, Roberto, Shakur-Still, Haleema, Medcalf, Robert L., Standing, Joseph F., Roberts, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365258/ https://www.ncbi.nlm.nih.gov/pubmed/30585835 http://dx.doi.org/10.1097/MBC.0000000000000789 |
Ejemplares similares
-
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers
por: Kane, Zoe, et al.
Publicado: (2021) -
Tranexamic acid for post-partum haemorrhage: What, who and when
por: Brenner, Amy, et al.
Publicado: (2019) -
Effects of tranexamic acid treatment in severely and non‐severely injured trauma patients
por: Ageron, Francois‐Xavier, et al.
Publicado: (2022) -
A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan
por: Mahmood, Abda, et al.
Publicado: (2019) -
A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury
por: Williams, Jack, et al.
Publicado: (2022)